As of 2024-12-14, the Intrinsic Value of Biotech Growth Trust PLC (BIOG.L) is
2,274.57 GBP. This BIOG.L valuation is based on the model Discounted Cash Flows (Growth Exit 5Y).
With the current market price of 885.00 GBP, the upside of Biotech Growth Trust PLC is
157.00%.
The range of the Intrinsic Value is 1,954.14 - 2,730.56 GBP
2,274.57 GBP
Intrinsic Value
BIOG.L Intrinsic Value - Valuation Summary
|
Range |
Selected |
Upside |
a |
DCF (Growth 5y) |
1,954.14 - 2,730.56 |
2,274.57 |
157.0% |
DCF (Growth 10y) |
2,178.62 - 2,987.37 |
2,514.61 |
184.1% |
DCF (EBITDA 5y) |
1,498.33 - 1,793.65 |
1,630.28 |
84.2% |
DCF (EBITDA 10y) |
1,876.19 - 2,287.07 |
2,061.05 |
132.9% |
Fair Value |
5,617.65 - 5,617.65 |
5,617.65 |
534.76% |
P/E |
1,303.30 - 2,812.19 |
1,750.03 |
97.7% |
EV/EBITDA |
986.04 - 1,756.11 |
1,097.61 |
24.0% |
EPV |
(1,516.90) - (1,899.69) |
(1,708.30) |
-293.0% |
DDM - Stable |
1,174.52 - 2,146.78 |
1,660.65 |
87.6% |
DDM - Multi |
1,191.79 - 1,780.22 |
1,433.77 |
62.0% |
BIOG.L Intrinsic Value - Key Valuation Metrics
Market Cap (mil) |
293.81 |
Beta |
0.65 |
Outstanding shares (mil) |
0.33 |
Enterprise Value (mil) |
338.76 |
Market risk premium |
5.98% |
Cost of Equity |
11.91% |
Cost of Debt |
4.29% |
WACC |
10.85% |